BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32340368)

  • 1. RNA-Targeted Therapies and High-Throughput Screening Methods.
    Zhu S; Rooney S; Michlewski G
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting RNA structures in diseases with small molecules.
    Shao Y; Zhang QC
    Essays Biochem; 2020 Dec; 64(6):955-966. PubMed ID: 33078198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery.
    D'Agostino VG; Sighel D; Zucal C; Bonomo I; Micaelli M; Lolli G; Provenzani A; Quattrone A; Adami V
    SLAS Discov; 2019 Mar; 24(3):314-331. PubMed ID: 30616427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput characterization of protein-RNA interactions.
    Cook KB; Hughes TR; Morris QD
    Brief Funct Genomics; 2015 Jan; 14(1):74-89. PubMed ID: 25504152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of small molecule inhibitors of the Lin28-mediated blockage of pre-let-7g processing.
    Lightfoot HL; Miska EA; Balasubramanian S
    Org Biomol Chem; 2016 Nov; 14(43):10208-10216. PubMed ID: 27731469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-Binding Proteins in Cancer: Old Players and New Actors.
    Pereira B; Billaud M; Almeida R
    Trends Cancer; 2017 Jul; 3(7):506-528. PubMed ID: 28718405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to target RNA binding proteins.
    Julio AR; Backus KM
    Curr Opin Chem Biol; 2021 Jun; 62():13-23. PubMed ID: 33535093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Small-Molecule Modulators of Protein-RNA Interactions by Fluorescence Intensity-Based Binding Assay.
    Byun WG; Lim D; Park SB
    Chembiochem; 2020 Mar; 21(6):818-824. PubMed ID: 31587454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications.
    Nutter CA; Kuyumcu-Martinez MN
    Wiley Interdiscip Rev RNA; 2018 Mar; 9(2):. PubMed ID: 29280295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELAV proteins along evolution: back to the nucleus?
    Colombrita C; Silani V; Ratti A
    Mol Cell Neurosci; 2013 Sep; 56():447-55. PubMed ID: 23439364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
    Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
    ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegeneration and RNA-binding proteins.
    De Conti L; Baralle M; Buratti E
    Wiley Interdiscip Rev RNA; 2017 Mar; 8(2):. PubMed ID: 27659427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-binding proteins in human genetic disease.
    Lukong KE; Chang KW; Khandjian EW; Richard S
    Trends Genet; 2008 Aug; 24(8):416-25. PubMed ID: 18597886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
    Poller W; Tank J; Skurk C; Gast M
    Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage: RNA-binding proteins protect from near and far.
    Dutertre M; Lambert S; Carreira A; Amor-Guéret M; Vagner S
    Trends Biochem Sci; 2014 Mar; 39(3):141-9. PubMed ID: 24534650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.
    Wu M; Tong CWS; Yan W; To KKW; Cho WCS
    Curr Cancer Drug Targets; 2019; 19(5):382-399. PubMed ID: 30381077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
    Bashraheel SS; Domling A; Goda SK
    Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.
    Kudinov AE; Karanicolas J; Golemis EA; Boumber Y
    Clin Cancer Res; 2017 May; 23(9):2143-2153. PubMed ID: 28143872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live cell screening to identify RNA-binding small molecule inhibitors of the pre-let-7-Lin28 RNA-protein interaction.
    Rosenblum SL; Soueid DM; Giambasu G; Vander Roest S; Pasternak A; DiMauro EF; Simov V; Garner AL
    RSC Med Chem; 2024 May; 15(5):1539-1546. PubMed ID: 38784453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of RNA metabolism-related genes in mouse but not human tissues deficient in SMN.
    Olaso R; Joshi V; Fernandez J; Roblot N; Courageot S; Bonnefont JP; Melki J
    Physiol Genomics; 2006 Jan; 24(2):97-104. PubMed ID: 16118268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.